Primary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterized by hypogammaglobulinemia and increased susceptibility to bacterial infections, leading to hospitalizations. This study was performed to determine the main infectious causes of hospital admissions in selective Iranian patients with PADs. Forty patients with PADs, who were admitted to the Infectious Ward of Children's Medical Center Hospital during a 14-year period, were reviewed in this study. There were 115 documented episodes of hospital admission during a 14-year period. The average length of hospital stay was 33.30 ± 25.72 days. Pneumonia was the most prominent infection leading to hospitalization among these patients (n = 48), followed by gastroen...
Background: Frequent infections is among the most frequent clinical dilemmas for primary care physic...
Copyright © 2013 Eduardo Guanı́-Guerra et al. This is an open access article distributed under the C...
Background Despite recent pharmaceutical advancements in the production of new antibiotics...
AbstractPrimary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterized b...
Background: Primary antibody deficiency (PAD) is the most common group of primary immunodeficiency d...
Bacterial respiratory tract infections are the hallmark of primary antibody deficiencies (PADs). Bec...
BackgroundPrimary antibody deficiencies (PADs) are heterogeneous group of disorders, characterized b...
Background: Primary antibody deficiency (PAD) comprises a range of diseases from early to late termi...
textabstractPrimary antibody deficiencies (PADs) are the most common primary immunodeficiencies and ...
Introduction: Respiratory tract infections constitute the most frequent manifestation of X-linked ...
Antibodydeficiencies Epidemiology, Clinical manifestation, Diagnostics and Therapy Abstract. Primary...
Abstract Background and objectives: In diabetic patients, infectious disease is one of the most impo...
Primary antibody deficiencies (PAD) are a group of disorders characterized by reduced antibody produ...
Contains fulltext : 200247.pdf (publisher's version ) (Open Access)Background: Mos...
Primary antibody deficiency is the most common disorder among primary immunodeficiencies. Recurrent ...
Background: Frequent infections is among the most frequent clinical dilemmas for primary care physic...
Copyright © 2013 Eduardo Guanı́-Guerra et al. This is an open access article distributed under the C...
Background Despite recent pharmaceutical advancements in the production of new antibiotics...
AbstractPrimary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterized b...
Background: Primary antibody deficiency (PAD) is the most common group of primary immunodeficiency d...
Bacterial respiratory tract infections are the hallmark of primary antibody deficiencies (PADs). Bec...
BackgroundPrimary antibody deficiencies (PADs) are heterogeneous group of disorders, characterized b...
Background: Primary antibody deficiency (PAD) comprises a range of diseases from early to late termi...
textabstractPrimary antibody deficiencies (PADs) are the most common primary immunodeficiencies and ...
Introduction: Respiratory tract infections constitute the most frequent manifestation of X-linked ...
Antibodydeficiencies Epidemiology, Clinical manifestation, Diagnostics and Therapy Abstract. Primary...
Abstract Background and objectives: In diabetic patients, infectious disease is one of the most impo...
Primary antibody deficiencies (PAD) are a group of disorders characterized by reduced antibody produ...
Contains fulltext : 200247.pdf (publisher's version ) (Open Access)Background: Mos...
Primary antibody deficiency is the most common disorder among primary immunodeficiencies. Recurrent ...
Background: Frequent infections is among the most frequent clinical dilemmas for primary care physic...
Copyright © 2013 Eduardo Guanı́-Guerra et al. This is an open access article distributed under the C...
Background Despite recent pharmaceutical advancements in the production of new antibiotics...